BridgeBio Oncology and Helix Acquisition Announce Merger to Create Biotech Company

BridgeBio Oncology and Helix Acquisition Announce Merger to Create Biotech Company BridgeBio Oncology Therapeutics (BBOT), a clinical-stage biopharmaceutical company focused on developing novel small molecule therapeutics for RAS and PI3Kα-targeted malignancies, and Helix Acquisition Corp. II (Nasdaq: HLXB), a special…

Read MoreBridgeBio Oncology and Helix Acquisition Announce Merger to Create Biotech Company

Astria Therapeutics Launches Phase 3 ALPHA-ORBIT Trial of Navenibart for Hereditary Angioedema

Astria Therapeutics Launches Phase 3 ALPHA-ORBIT Trial of Navenibart for Hereditary Angioedema Astria Therapeutics, Inc. (Nasdaq: ATXS), a biopharmaceutical company dedicated to developing transformative therapies for allergic and immune diseases, has announced the launch of the Phase 3 ALPHA-ORBIT clinical…

Read MoreAstria Therapeutics Launches Phase 3 ALPHA-ORBIT Trial of Navenibart for Hereditary Angioedema

athenahealth Showcases AI, Interoperability, and Market Solutions at HIMSS 2025

athenahealth Showcases AI, Interoperability, and Market Solutions at HIMSS 2025 athenahealth, a leading provider of network-enabled software and services for healthcare practices across the country, will be showcasing its innovations at HIMSS, taking place March 3-6. The company will highlight…

Read Moreathenahealth Showcases AI, Interoperability, and Market Solutions at HIMSS 2025

Validic Unveils Health IoT and Remote Patient Management Solutions with Generative AI on AWS Marketplace

Validic Unveils Health IoT and Remote Patient Management Solutions with Generative AI on AWS Marketplace Validic, a leader in healthcare technology innovation, has announced the launch of its full suite of Intelligent Digital Care Solutions and Services on AWS Marketplace.…

Read MoreValidic Unveils Health IoT and Remote Patient Management Solutions with Generative AI on AWS Marketplace

Adagio Medical Announces Restructuring to Accelerate US IDE Trial and Innovation

Adagio Medical Announces Restructuring to Accelerate US IDE Trial and Innovation Adagio Medical Holdings, Inc. (Nasdaq: ADGM), a leader in catheter ablation technologies for treating cardiac arrhythmias, today announced a strategic restructuring aimed at prioritizing its FULCRUM-VT US pivotal investigational…

Read MoreAdagio Medical Announces Restructuring to Accelerate US IDE Trial and Innovation

Waystar Expands Authorization Automation to Meet Healthcare Providers’ 2025 Priorities

Waystar Expands Authorization Automation to Meet Healthcare Providers’ 2025 Priorities Waystar (Nasdaq: WAY), a leading provider of healthcare payment software, has introduced the Auth Accelerate solution, a significant enhancement to its automation capabilities aimed at simplifying the prior authorization process…

Read MoreWaystar Expands Authorization Automation to Meet Healthcare Providers’ 2025 Priorities